CPhI South East Asia was launched in 2012 as an extension of the worldwide leading event for the pharmaceutical ingredients: CPhI, to serve the South East Asia region with more focus. South East Asia is a region with high growth and great potential. The total population is about 560 million people with developing healthcare access and consequently needs for medicine also rises creating a huge opportunity for the pharmaceutical industry.
The addition of P-MEC in 2013 served to highlight the growth of the finished dosage and generics sectors, which is currently being driven by rapid growth in the manufacture base of South East Asia.
The introduction of InnoPack further extended the scope of the event by bringing a focus to the important role that packaging plays in product development, safety, dosage and dispensing.
UBM EMEA is a division of UBM Plc (LSE: UBM) - a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in over 30 countries and are organized into specialist teams that serve their business communities by helping them excel in their market by working effectively and efficiently.